TRIO L-06

Lung Small Cell - TRIO L-06

TRIO L-06

Objective

An Open-Label Phase Ib/II Trial of Niraparib and Temozolomide with Atezolizumab vs. Atezolizumab alone as Maintenance Therapy for Extensive Stage Small Cell Lung Cancer

Principal Investigator(s)
Thomas Lowe, MD

Clinical Trial Categories

  • UCLA Trio Clinical Trials